Please assess the completion status of the following clinical trial:

Trial Title: Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* abdominal-thoracic esophagectomy with radical lymphadenectomy~* post operative admission to ICU~* age \>= 18 yrs~* written informed consent~Exclusion Criteria:~* Participation in another interventional trial~* pregnancy or lactation~* systemic medication with high dose steroids and/or immunosuppressants and/or radiotherapy during the last 3 months~* known diseases of the immune system (benign and malign)~* contraindications for extracorporeal therapy~* Thrombocytopenia \< 50\*10\^9/l~* therapy limitations (DNR), moribund status~* missing informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Care (Type: NO_INTERVENTION): intensive care therapy according to international standards and following local SOPs, including fluid therapy, mechanical ventilation, catecholamine therapy and other pharmacotherapy as required
- CytoSorb (Type: EXPERIMENTAL): all of the above, plus extracorporeal hemadsorption therapy (CytoSorbents Adsorber cartridge) using continuous veno-venous hemofiltration (citrate anticoagulation) CytoSorb cytokine elimination

Based on this trial design, predict the completion outcome and termination type (if applicable).